For your patients

More in this category

• Pediatric surgeons and gastroenterologists collaborate with outpatient community services to streamline outpatient gastrostomy tube placement
• Prophylactic hyperthermic intraperitoneal chemotherapy in gastric cancer
• NCDB trends in young women with metastatic breast cancer diagnosis since screening guideline changes were instituted
• Managing postoperative pain while limiting opioid prescriptions
• New trial aims to settle debate on the intensity of pancreatic cyst surveillance
• Trends in perioperative treatment of gastric cancer 2004–2017: An NCDB analysis
• Virtual acute care for older patients reduces hospital length of stay
• Ga-68 imaging changes clinical management of GI and pancreatic neuroendocrine tumors
• Neoadjuvant and perioperative chemotherapy for localized pancreatic cancer: Leveraging small and large databases in the absence of Level 1 evidence
• Early-stage prostate cancer decision aids for diverse patient populations
• Keep calm and stay out of the ICU: A comprehensive approach to reducing unplanned ICU admissions
• Postoperative pain and nausea protocols decrease LOS without increasing readmissions after laparoscopic gastric bypass
• What is the National Clinical Trials Network, and how do I join?
• Hospital-based preoperative clinic applies ERAS and Strong for Surgery guidelines to optimize patients for surgery
• ACS Clinical Research Program sessions at Clinical Congress 2019: A recap
• Biliary tract cancers: NCDB role in rare malignancy
• ERAS leads to reduced length of stay for geriatric joint replacement patients
• Modified FOLFIRINOX is superior to gemcitabine as adjuvant therapy for resected pancreatic cancer: The PRODIGE 24/CCTG PA6 Trial
• ERAS program improves outcomes in patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy
• ALCHEMIST trial has potential to improve outcomes after lung cancer resection